Applied DNA Sciences (NASDAQ:APDN) Coverage Initiated by Analysts at StockNews.com

Posted by ABMN Staff on Mar 18th, 2025

StockNews.com started coverage on shares of Applied DNA Sciences (NASDAQ:APDN – Free Report) in a research note published on Monday. The brokerage issued a sell rating on the technology company’s stock.

Applied DNA Sciences Stock Performance

APDN opened at $1.83 on Monday. Applied DNA Sciences has a fifty-two week low of $1.81 and a fifty-two week high of $522.00. The company has a fifty day moving average of $0.24 and a two-hundred day moving average of $0.40. The stock has a market capitalization of $2.02 million, a price-to-earnings ratio of -0.32 and a beta of 0.43.

Applied DNA Sciences (NASDAQ:APDN – Get Free Report) last released its quarterly earnings data on Thursday, February 13th. The technology company reported ($0.56) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.32) by ($0.24). Applied DNA Sciences had a negative net margin of 228.12% and a negative return on equity of 101.57%. On average, equities research analysts forecast that Applied DNA Sciences will post -0.87 earnings per share for the current year.

Institutional Trading of Applied DNA Sciences

Institutional investors and hedge funds have recently modified their holdings of the stock. Jane Street Group LLC purchased a new stake in shares of Applied DNA Sciences during the third quarter worth about $48,000. Millennium Management LLC purchased a new stake in shares of Applied DNA Sciences during the fourth quarter worth about $28,000. Connective Capital Management LLC purchased a new stake in shares of Applied DNA Sciences during the fourth quarter worth about $36,000. Finally, Geode Capital Management LLC increased its stake in shares of Applied DNA Sciences by 291.1% during the fourth quarter. Geode Capital Management LLC now owns 417,485 shares of the technology company’s stock worth $85,000 after purchasing an additional 310,749 shares in the last quarter. Hedge funds and other institutional investors own 22.22% of the company’s stock.

Applied DNA Sciences Company Profile

(Get Free Report)

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.